Targeting Epithelial Growth Factor Receptor (EGFR) With Cetuximab in Combination With Irinotecan as Salvage Treatment in Refractory Gastric Cancer Patients: A Retrospective Analysis and Review of the Literature
Standard
Targeting Epithelial Growth Factor Receptor (EGFR) With Cetuximab in Combination With Irinotecan as Salvage Treatment in Refractory Gastric Cancer Patients: A Retrospective Analysis and Review of the Literature. / Stein, Alexander; Peinert, Stefan; Al-Batran, Salah-Eddin; Arnold, Dirk.
In: Eur J Clin Med Oncol, Vol. 4, No. 1, 1, 2012, p. 11-17.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Targeting Epithelial Growth Factor Receptor (EGFR) With Cetuximab in Combination With Irinotecan as Salvage Treatment in Refractory Gastric Cancer Patients: A Retrospective Analysis and Review of the Literature
AU - Stein, Alexander
AU - Peinert, Stefan
AU - Al-Batran, Salah-Eddin
AU - Arnold, Dirk
PY - 2012
Y1 - 2012
M3 - SCORING: Zeitschriftenaufsatz
VL - 4
SP - 11
EP - 17
JO - Eur J Clin Med Oncol
JF - Eur J Clin Med Oncol
SN - 1759-8958
IS - 1
M1 - 1
ER -